Rotterdam Eye Hospital Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2009
NCT00929019
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

povidone-iodine (betadine) (1 trial)

Drugs in Phase 2 Trials (1)

autologous dendritic cells electroporated with wt1 mrna (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Endophthalmitis (Phase 4)

Melanoma (Phase 2)

Strabismus (Phase 4)

Uveal Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2